SCHEMBL6285702

SCHEMBL6285702

O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1C(=O)c1ccco1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 6/20 0.46
TSHR P16473 2/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
NOX1 Q9Y5S8 1/20 0.46
POLB P06746 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
KDM4E B2RXH2 3/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
F2 P00734 1/20 0.42
HPGD P15428 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 2/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14353586 0.74 POLB (0.60) L3MBTL1POLBTDP1KMT2AMEN1
SCHEMBL6281897 0.72 POLB (0.45) L3MBTL1POLBTDP1KDM4EKMT2A
SCHEMBL6284061 0.71 BCHE (0.47) L3MBTL1ALDH1A1LMNAPOLBTDP1
SCHEMBL6282586 0.71 BCHE (0.47) TSHRLMNAPOLBTDP1KMT2A
SCHEMBL15285410 0.70 ALDH1A1 (0.75) L3MBTL1ALDH1A1TSHRMAPTLMNA
SCHEMBL11432635 0.69 POLB (0.54) POLBTDP1KMT2AMEN1
SCHEMBL15461427 0.69 TDP1 (0.60) MAPTPOLBTDP1GAAKMT2A
SCHEMBL23954175 0.67 ALDH1A1 (0.49) L3MBTL1ALDH1A1TSHRMAPTLMNA
SCHEMBL14353660 0.67 POLB (0.51) POLBTDP1KMT2AMEN1
SCHEMBL14353612 0.67 POLB (0.54) L3MBTL1ALDH1A1MAPTPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919365-B2 Imidazolidinedione derivatives and use thereof as drugs SENJU PHARMACEUTICAL CO., LTD. (JP) 2005-07-19 US disclosed
US-20040110811-A1 Novel imidazolidinedione derivatives and use thereof as drugs SENJU PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
EP-1384715-A1 NOVEL IMIDAZOLIDINEDIONE DERIVATIVES AND USE THEREOF AS DRUGS Senju Pharmaceutical Co., Ltd. (JP) 2004-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110811-A1 Novel imidazolidinedione derivatives and use thereof as drugs CMA1, TPSD1, TPSB2 L3MBTL1 4709/4885ALDH1A1 270/4885TSHR 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.